Don't Be Afraid of the Dark Genome: New Therapies from Regulatory Non-Coding RNA

The COVID-19 pandemic significantly changed the RNA landscape, with new and exciting technologies tapping into the power of RNA, using it to derive groundbreaking delivery methods or identify new RNA-based targets. The next generation of genetic medicines is set to target non-coding RNAs and the Dark Genome – the non-coding genomic regions of the regulatory genome which is now known to play an important role in disease. Four companies are now setting their sights on the Dark Genome and leveraging new advanced tools to create safer, more effective precision therapies. Join a panel of thought leaders in the space who are leveraging the power of the Dark Genome that will hopefully lead to improved medicines for chronic, hard-to-treat diseases.